Is CHWY a Buy or a Sell? The Bull and Bear Case (2026)
Last updated July 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Chewy (CHWY) rests on Autoship makes the revenue sticky: Autoship, Chewy's auto-replenishment subscription, drives roughly 83% of net sales, which is rare predictability for a retailer. The bear case rests on chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Analysts covering it publish targets from $22.00 to $42.00 against a $22.68 price, so even the professionals disagree by 64% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Chewy is the largest pure-play online retailer of pet products in the United States, selling pet food, treats, supplies, prescription medications, and other essentials, plus a growing set of pet-health services. The core of the model is Autoship, an auto-replenishment subscription that schedules recurring deliveries of food and supplies; Autoship accounts for roughly 83% of net sales, which gives Chewy unusually predictable, repeat-purchase revenue for a retailer. The company makes most of its money on product sales at retail-style gross margins, but it is steadily mixing in higher-margin revenue from Chewy Pharmacy, sponsored ads through its Chewy Ads retail-media network, and veterinary care. In fiscal 2025 (the year ended February 1, 2026) Chewy reported net sales of about $12.60 billion, up 6.2% (roughly 8.3% on a comparable 52-week basis), with around 21.3 million active customers and net sales per active customer near $600. Chewy was founded in 2011, sold to PetSmart in 2017, and went public in 2019; the private-equity firm BC Partners (through its PetSmart ownership) was the longtime majority holder and has been steadily selling down its stake through secondary offerings, often paired with Chewy share buybacks. Profitability has improved markedly: fiscal 2025 net income was about $222.8 million, adjusted EBITDA reached roughly $719 million (up about 26%), and free cash flow hit a record near $562 million. Management has leaned into two growth bets in particular: a fast-scaling retail-media advertising business that executives credit as a main driver of gross-margin gains, and a push into veterinary care, including the 2026 agreement to acquire Modern Animal, which lifted Chewy Vet Care's clinic footprint from 18 toward 47 sites with a target of roughly 60. In the first quarter of fiscal 2026 (ended May 3, 2026), net sales grew 7.7% to about $3.36 billion with net income of $94.8 million.
The bull case: what would have to be true for $42.00
The most optimistic published target on CHWY is $42.00, +85.2% from the $22.68 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Autoship makes the revenue sticky.
Autoship, Chewy's auto-replenishment subscription, drives roughly 83% of net sales, which is rare predictability for a retailer. Pet food and medications are non-discretionary, repeat purchases, so the base tends to hold up even in weaker consumer environments. With around 21.3 million active customers and net sales per active customer near $600, the model compounds as existing customers buy more categories. The strategic question is less about losing customers and more about how much more Chewy can sell each one.
2. Higher-margin businesses are the profit lever.
Chewy is layering more profitable revenue on top of low-margin product sales. The Chewy Ads retail-media network, launched in 2023, has roughly doubled its advertisers and is the business management credits as a primary driver of gross-margin expansion. Gross margin reached about 29.8% in fiscal 2025 and 30.1% in the first quarter of fiscal 2026. Chewy Pharmacy adds another structurally higher-margin stream, helping adjusted EBITDA margin climb toward the mid-single digits with guidance around 6.6% to 6.8% for fiscal 2026.
3. Vet care extends the ecosystem.
Chewy is building a physical pet-health footprint to capture more of the roughly $40 billion Americans spend on pet healthcare. Its 2026 agreement to acquire Modern Animal lifts Chewy Vet Care from 18 clinics toward 47, with a target of around 60 locations, and is expected to add more than $125 million of annualized run-rate revenue. Management expects clinic customers to spend meaningfully more across Chewy overall. The clinics are an investment that is expected to break even around 2026 and contribute to profit later, so the payoff is multi-year.
4. Cash generation and buybacks.
Chewy is now firmly cash-generative, posting record free cash flow of about $562 million in fiscal 2025. It returns capital through share repurchases rather than a dividend, deploying roughly $200 million on buybacks in the first quarter of fiscal 2026 alone, often alongside secondary offerings as BC Partners sells down its stake. Net income of about $222.8 million in fiscal 2025 and $94.8 million in the latest quarter show the business is profitable on a GAAP basis. The buyback program also helps offset dilution from share-based compensation, which remains a meaningful expense.
The bear case: what would have to be true for $22.00
The most pessimistic published target is $22.00, -3.0% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Chewy is worth if the risks below bite instead of the drivers above.
Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Growth has slowed as the US pet market matures, with net sales up only about 6% in fiscal 2025 and active-customer growth modest after a long stretch of flat-to-declining counts following the pandemic pet boom. Competition is intense and well-capitalized: Amazon, Walmart, big-box pet chains like PetSmart and Petco, and local veterinarians all compete for the same wallet. The vet-clinic expansion carries execution and integration risk and weighs on near-term profit, while share-based compensation and ongoing BC Partners stock sales create dilution and overhang. Finally, the stock often trades at a premium that already bakes in continued margin gains, so disappointing customer growth or margin progress can pressure the shares.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding CHWY already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on CHWY
21 analysts cover CHWY, with an average target of $31.05 (+36.9% against $22.68) and a split of 20 buy, 5 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the CHWY forecast and price target page.
How is CHWY valued? (as of FY2025 results (year ended February 1, 2026) and Q1 FY2026 (ended May 3, 2026))
Snapshot for CHWY as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- FY2025 net sales: About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis)
- FY2025 net income: About $222.8 million
- FY2025 adjusted EBITDA: About $719 million, up roughly 26%
- FY2025 free cash flow: Record of about $562 million
- Active customers / Autoship: Around 21.3 million active customers; Autoship roughly 83% of net sales
- Q1 FY2026 quarter: Net sales about $3.36 billion (+7.7%), net income $94.8 million, diluted EPS $0.23, gross margin 30.1%
Chewy is best read as a profitable but low-margin retailer that is trying to mix in higher-margin revenue, so watch the trend in gross margin and adjusted EBITDA margin more than headline sales growth. Because product sales dominate, net margins are thin (low single digits), and free cash flow is often a cleaner gauge of health than GAAP net income, which can be swung by share-based compensation and tax items. Active-customer growth and net sales per active customer show whether the base is expanding or just spending more. Since Chewy pays no dividend and reinvests in pharmacy, ads, and vet care while buying back stock, the valuation hinges on whether those higher-margin businesses scale fast enough to justify a growth multiple.
How do you decide if CHWY is a buy?
Rather than asking whether CHWY is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CHWY indirectly through an index or sector ETF before adding more.
What would change your mind on CHWY
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Autoship makes the revenue sticky stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the CHWY stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CHWY against your real portfolio and see your actual exposure before deciding.
Investing in Chewy with AI
Connect the broker you already use and ask Walnut's AI how CHWY fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is CHWY a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Autoship makes the revenue sticky, with fy2025 net sales at About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis). The bear case rests on chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Analysts covering it are spread from $22.00 to $42.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell CHWY?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $22.00, -3.0% from the $22.68 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for CHWY?
+
Autoship makes the revenue sticky. Autoship, Chewy's auto-replenishment subscription, drives roughly 83% of net sales, which is rare predictability for a retailer. The most optimistic analyst target on CHWY is $42.00, +85.2% from the $22.68 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for CHWY?
+
Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Growth has slowed as the US pet market matures, with net sales up only about 6% in fiscal 2025 and active-customer growth modest after a long stretch of flat-to-declining counts following the pandemic pet boom. Competition is intense and well-capitalized: Amazon, Walmart, big-box pet chains like PetSmart and Petco, and local veterinarians all compete for the same wallet. The vet-clinic expansion carries execution and integration risk and weighs on near-term profit, while share-based compensation and ongoing BC Partners stock sales create dilution and overhang. Finally, the stock often trades at a premium that already bakes in continued margin gains, so disappointing customer growth or margin progress can pressure the shares. The most pessimistic published target is $22.00, -3.0% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Chewy do?
+
The largest US online pet retailer, built around its Autoship subscription and expanding into higher-margin pharmacy, advertising, and vet-care businesses.
What would have to change for CHWY to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Autoship makes the revenue sticky) stalling in the reported numbers rather than in the narrative, the risk above (chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Chewy do?
+
Chewy is the largest online retailer of pet products in the US. It sells pet food, treats, supplies, and prescription medications, mostly through its Autoship auto-replenishment subscription, and is expanding into pet healthcare with Chewy Pharmacy, a retail-media advertising network, and a growing chain of Chewy Vet Care clinics.
Does CHWY pay a dividend?
+
No. Chewy does not pay a dividend. It returns capital to shareholders through share repurchases instead, deploying roughly $200 million on buybacks in the first quarter of fiscal 2026, partly to offset dilution from share-based compensation and stock sold by its longtime backer BC Partners.
What is Autoship and why does it matter?
+
Autoship is Chewy's subscription that automatically reships food and supplies on a set schedule. It accounts for roughly 83% of net sales, which gives Chewy unusually predictable, recurring revenue for a retailer because pet food and medications are repeat, non-discretionary purchases.
Walnut is informational, not investment advice, and gives no verdict on CHWY. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature CHWY
CHWY is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.